FOLH1 and prostate carcinoma: Similar to our study, Ferraro et al. reported that [68Ga]Ga-PSMA-11 PET-CT had a sensitivity of 58% and a specificity of 98% for predicting LNI in patients with intermediate-to-high-risk prostate cancer [35].